An Israeli biotech company claims that its preliminary research on mice gave hope of treating cancer within a year, the Newshub reported.
According to a Jerusalem Post report, the Israeli company announced it has developed a cure for the fight against cancer using peptides.
Peptides are amino acid-related compounds in the chain that the company uses to attack and kill cancer cells in mice.
Chairman of the Board of Directors, Dan Aridor, told the Jerusalem Post that the company has high hopes for drugs.
"We believe that we will offer in a year, a complete cure for cancer."
However, the company has just tested its drug mice. It can take up to seven years to bring cancer drugs to the market, even with special permissions from US regulators, reports CNBC.
Company Biotechnology has yet to publish clinical evidence to prove that treatment is effective in humans.
His executive director Ilan Mora told the "Jerusalem Post" that he had just completed his first mouse experiment, which he claims to have been successful.
Before a drug can move from people's mice, it must undergo rigorous testing according to the Food and Drug Administration.
First laboratory and animal tests must be carried out.
If this evidence is effective and safe, the drug may be moved to human trials.